Results 151 to 160 of about 50,409 (184)

Targeting ICMT: A promising strategy in cancer treatment (Review). [PDF]

Oncol Lett
Hu J, Xiao Y, Tang J.
europepmc   +1 more source

Enhanced Killing of Colon Cancer Cells by Mesoporous Silica Nanoparticles Loaded with Ellagic Acid. [PDF]

Nanomaterials (Basel)
AbouAitah K, Nassrallah A, Soliman AAF, Swiderska-Sroda A, Chudoba T, Smalc-Koziorowska J, Kim BS, Łojkowski W.   +7 more
europepmc   +1 more source

Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer. [PDF]

Transl Oncol
Gazzah A, Ternès N, Lee JS, Wang E, Carene D, Wang H, Masson N, Boitier E, Lartigau A, Mace N, Chadjaa M, Dib C, Nunes M, Muzard G, Longuemaux-Valence S, Bauchet AL.   +15 more
europepmc   +1 more source

RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236. [PDF]

Clin Cancer Res
Pfeil AJ, Zhang T, Cheng R, Mattar MS, Gomez Marti JL, Gili L, Lai R, Khodos I, Master RP, Dix JM, Gazzo A, Arbour KC, de Stanchina E, Febres-Aldana CA, Ladanyi M, Yang SR, Somwar R.   +16 more
europepmc   +1 more source

Repurposing Ilaprazole as a PP5 TPR Domain Binder with Modulatory Effects on MAPK Signaling. [PDF]

ACS Med Chem Lett
He Y, Gu J, Hua L, Zhai D, Huang Q, Pei J, You Q, Zhang Q, Wang L.   +8 more
europepmc   +1 more source

TRAF7 in signaling and disease: emerging mechanisms and clinical implications. [PDF]

Mol Med
Orock A, Zuccato JA, Phan K, Liu Y, Ihuoma J, Tavakol S, Tsytsykova AV, Tsitsikov EN, Tarantini S, Johnson AC, Dunn IF.   +10 more
europepmc   +1 more source

Real-Time Visualization of Isoform-Specific RAF-KRAS Interactions in Living Cells Using FRET-BRET Hybrid Biosensors. [PDF]

Adv Sci (Weinh)
Go JM, Lee D, Kim M, Han K, Choi G, Song C, Ahn S, Lee Y, Lee J, Wang Y, Suh JS, Yun H, Kim TJ.   +12 more
europepmc   +1 more source

Development of a UPLC-MS/MS method and its application for the pharmacokinetic analysis of regorafenib in rats. [PDF]

Sci Rep
Otto F, Propisnova V, Urjasz H, Lewandowski K, Sarnowski K, Szałek E, Karbownik A.   +6 more
europepmc   +1 more source

In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers. [PDF]

Front Cell Dev Biol
Baspakova A, Zare A, Mussin NM, Tanideh N, Zhilisbayeva KR, Safarzoda Sharoffidin R, Suleimenova R, Yelgondina G, Kaliyeva AE, Umbetova AA, Zinaliyeva A, Tamadon A.   +11 more
europepmc   +1 more source